Jack Murtha

A University of Pennsylvania medical informatics expert describes how healthcare organizations can crunch the numbers to their advantage.

Researchers say the guidelines fill a void in many medical schools.

Researchers want to help hospitals improve outcomes and cut costs.

The powerhouse team wants to use data to help patients and providers.

The Integrated Health Model Initiative aspires to improve data practices to strengthen care.

A report from McAfee Labs found that the industry suffered the most security incidents of the 2nd quarter.

A study found ophthalmologists spent 3.7 hours per day in the system.

How they hope to safeguard patient information on the Internet of Medical Things.

A new study of brain imaging results reiterates the need to focus on gathering quality information.

Researchers used whole genome sequencing to identify a genetic signature for the disorder.

Why the trade group wants integration, standardization, and participation from all stakeholders.

Why the website’s banking on crowdsourced trial predictions, data visualizations, and community.

Qiagen and Centogene AG hope to use sprawling data sets and AI to improve clinical prediction.

Lessons from GlaxoSmithKline’s app-based study can benefit healthcare companies.

After hitting 3 key goals, GlaxoSmithKline’s PARADE could help change data collection.

What needs to happen before Alexa answers questions about your meds?

More often than you might think, panelists said. But only for the right reasons.

Risk is inherent, one Takeda exec said. But the potential is clear.

Takeda Pharmaceuticals uses this rubric to know what it’s getting into. You can, too.

And what healthcare executives and innovators can learn from its launch.

The method pushed people to exercise more often, a new study found.

How data could spur cost savings in treating a disease that's expected to cost $14.7B per year.

The National Institutes of Health says it’s one of the largest data sets ever made public.

As participants like Apple and Samsung prepare to huddle, Pear Therapeutics sees the upside.

The man who ran Medicare and Medicaid under President Obama speaks out.

And what can physicians learn from data linked to questionably prescribed pain meds?

The company’s largest round of funding underscores the strength of a device and an algorithm.

How data led to a discovery that could accelerate the development of new drugs.

Companies like Apple, Fitbit, and Johnson & Johnson are among those in a new pre-certification pilot program.

Why the Canadian genetic medicine startup Deep Genomics earned the money.